Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
TiGenix’s CEO leaves as operations integrate into Takeda
June 13, 2018 Off

TiGenix’s CEO leaves as operations integrate into Takeda

By Dino Mustafić

TiGenix NV’s Chief Executive Officer, Eduardo Bravo will depart the board of directors and his role as CEO of TiGenix…

4D cleared to study Blautix, its Irritable Bowel Syndrome treatment in UK and Ireland
June 13, 2018 Off

4D cleared to study Blautix, its Irritable Bowel Syndrome treatment in UK and Ireland

By Dino Mustafić

4D pharma has been cleared by the Medicines and Healthcare Products Regulatory Agency (MHRA) and the Health Products Regulatory Authority…

Santhera Pharmaceuticals submits NDA in South Korea for Raxone for the treatment of LHON
June 13, 2018 Off

Santhera Pharmaceuticals submits NDA in South Korea for Raxone for the treatment of LHON

By Dino Mustafić

Santhera Pharmaceuticals said on Tuesday that the Korean Ministry of Food and Drug Safety (MFDS) has accepted its new drug…

Keytruda becomes first anti-PD-1 therapy for patients with advanced cervical cancer
June 13, 2018 Off

Keytruda becomes first anti-PD-1 therapy for patients with advanced cervical cancer

By Dino Mustafić

The US Food and Drug Administration approved Merck’s Keytruda (pembrolizumab) for patients with recurrent or metastatic cervical cancer with disease…

Alvogen, Pfenex in a US marketed osteoporosis drug commercialization deal
June 12, 2018 Off

Alvogen, Pfenex in a US marketed osteoporosis drug commercialization deal

By Dino Mustafić

Alvogen and Pfenex have signed a deal which grants Alvogen exclusive rights to commercialize Pfenex’s lead drug candidate, PF708, a…

FDA grants Fast Track designation in the US for Nordic Nanovector’s Follicular Lymphoma drug
June 12, 2018 Off

FDA grants Fast Track designation in the US for Nordic Nanovector’s Follicular Lymphoma drug

By Dino Mustafić

The US Food & Drug Administration (FDA) has granted Fast Track designation to Nordic Nanovector’s Betalutin (177Lu-lilotomab satetraxetan) for the treatment of…

AstraZeneca and Eli Lilly quit Phase III clinical trials for Alzheimer’s disease drug
June 12, 2018 Off

AstraZeneca and Eli Lilly quit Phase III clinical trials for Alzheimer’s disease drug

By Dino Mustafić

AstraZeneca and Eli Lilly are abandoning the global Phase III clinical trials of lanabecestat, an oral beta secretase cleaving enzyme…

June 7, 2018 Off

Bayer closes Monsanto acquisition

By Dino Mustafić

Bayer successfully completed the acquisition of Monsanto on Thursday. Shares in the U.S. company will no longer be traded on the…

BioMarin bags $20 million in milestone payments
June 7, 2018 Off

BioMarin bags $20 million in milestone payments

By Dino Mustafić

BioMarin Pharmaceutical has received $20 million in milestone payments from Pfizer Inc, it said Thursday.

Merck, 4D evaluating Keytruda + 4D’s oncology programme for patients with solid tumours
June 7, 2018 Off

Merck, 4D evaluating Keytruda + 4D’s oncology programme for patients with solid tumours

By Dino Mustafić

A clinical stage biopharmaceutical company, 4D pharma, pioneering the development of Live Biotherapeutic Products, has made a deal with a subsidiary of…

Posts pagination

Previous 1 … 3,386 3,387 3,388 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine